We are live on ! Find out more
GLRA

Gerald L. Ray & Associates Portfolio holdings

AUM $802M
1-Year Est. Return 21.01%
This Fund
S&P 500
This Quarter Est. Return
+8.71%
1 Year Est. Return
+21.01%
3 Year Est. Return
+38.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$484M
AUM Growth
+$36.9M
Cap. Flow
+$6.09M
Cap. Flow %
1.26%
Top 10 Hldgs %
26.56%
Holding
273
New
13
Increased
78
Reduced
63
Closed
4

Top Buys

Rank Stock Value
1
ACAD icon
Acadia Pharmaceuticals
ACAD
+$973K
2
WY icon
Weyerhaeuser
WY
+$638K
3
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
+$453K
4
AIG icon
American International
AIG
+$430K
5
VNO icon
Vornado Realty Trust
VNO
+$423K

Top Sells

Rank Stock Value
1
NWSA
NEWS CORPORATION CL-A
NWSA
+$326K
2
SRPT icon
Sarepta Therapeutics
SRPT
+$272K
3
CP icon
Canadian Pacific Kansas City
CP
+$231K
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$224K
5
AMGN icon
Amgen
AMGN
+$169K

Sector Composition

Rank Sector Weight
1 Healthcare 22.9%
2 Industrials 12.46%
3 Consumer Staples 12.36%
4 Energy 9.49%
5 Technology 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CAT icon
26
Caterpillar
CAT
$387B
$5.01M 1.04%
60,111
+602
+1% +$50.9K
PFE icon
27
Pfizer
PFE
$144B
$5M 1.03%
183,524
+106
+0.1% +$2.88K
DIS icon
28
Walt Disney
DIS
$172B
$4.99M 1.03%
77,311
+325
+0.4% +$20.8K
KSU
29
DELISTED
Kansas City Southern
KSU
$4.92M 1.02%
44,950
– –
UAA icon
30
Under Armour
UAA
$3.04B
$4.86M 1%
246,352
+403
+0.2% +$7.06K
MMP
31
DELISTED
Magellan Midstream Partners, L.P.
MMP
$4.6M 0.95%
81,512
-500
-0.6% -$27.5K
UNH icon
32
UnitedHealth
UNH
$389B
$4.34M 0.9%
60,545
-100
-0.2% -$7.16K
CSCO icon
33
Cisco
CSCO
$456B
$4.33M 0.89%
184,655
+1,907
+1% +$47.3K
BA icon
34
Boeing
BA
$175B
$4.17M 0.86%
35,453
-49
-0.1% -$5.28K
CVX icon
35
Chevron
CVX
$374B
$4.16M 0.86%
34,254
+41
+0.1% +$5.04K
MSFT icon
36
Microsoft
MSFT
$2.92T
$4.02M 0.83%
120,842
+5,392
+5% +$177K
META icon
37
Meta Platforms (Facebook)
META
$1.51T
$3.96M 0.82%
78,935
+7,640
+11% +$284K
MRK icon
38
Merck
MRK
$326B
$3.73M 0.77%
82,015
+5
+0% +$228
SPG icon
39
Simon Property Group
SPG
$76.8B
$3.65M 0.76%
26,205
– –
VRTX icon
40
Vertex Pharmaceuticals
VRTX
$124B
$3.55M 0.73%
46,770
-300
-0.6% -$23.9K
GILD icon
41
Gilead Sciences
GILD
$167B
$3.46M 0.72%
55,120
+140
+0.3% +$8.37K
GS.PRA icon
42
Goldman Sachs Group Inc Depositary Shares
GS.PRA
$574M
$3.39M 0.7%
169,742
– –
KMP
43
DELISTED
KINDER MORGAN ENER PNTRS L.P.
KMP
$3.16M 0.65%
39,622
-100
-0.3% -$8.28K
EL icon
44
Estee Lauder
EL
$30.7B
$3.16M 0.65%
45,234
– –
TMO icon
45
Thermo Fisher Scientific
TMO
$214B
$3.13M 0.65%
33,965
– –
CBL
46
DELISTED
CBL& Associates Properties, Inc.
CBL
$3.03M 0.63%
158,679
– –
LVS icon
47
Las Vegas Sands
LVS
$32B
$2.96M 0.61%
44,550
-200
-0.4% -$11.6K
QCOM icon
48
Qualcomm
QCOM
$172B
$2.7M 0.56%
40,082
+4,834
+14% +$317K
ESRX
49
DELISTED
Express Scripts Holding Company
ESRX
$2.67M 0.55%
43,213
+650
+2% +$42K
RTX icon
50
RTX Corp
RTX
$295B
$2.65M 0.55%
38,973
– –
1
2
3 4 5

Similar funds

KRC
Kingdom Ridge Capital White Plains, New York $750M AUM 34.23% 1-Year Est. Return
GS
GAM Systematic Cambridge, United Kingdom $696M AUM 28.4% 1-Year Est. Return
PAAMCP
Pacific Alternative Asset Management Company (PAAMCO) Irvine, California $913M AUM 18.29% 1-Year Est. Return
B
BancorpSouth Tupelo, Mississippi $1.01B AUM 4.88% 1-Year Est. Return
JPCCM
J&P (China) Capital Management Hong Kong, China $586M AUM 82.64% 1-Year Est. Return
NBC
Neuberger Berman Canada Toronto, Ontario, Canada $542M AUM 14.17% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
SD
Sumway Development Shanghai, China $427M AUM 43.82% 1-Year Est. Return

Gerald L. Ray & Associates's Q3 2013 Portfolio in Review

As of Q3 2013, Gerald L. Ray & Associates held 273 positions worth $484M, up 8.3% from $447M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Gerald L. Ray & Associates's Q3 2013 filing shows 13 new, 78 increased, 63 reduced and 4 closed positions. Its largest new stake was Acadia Pharmaceuticals: 46,550 shares worth $1.28M. The largest sale was NEWS CORPORATION CL-A, an estimated $326K.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Industrials and Consumer Staples.

  • Gerald L. Ray & Associates's largest Q3 2013 buy was Acadia Pharmaceuticals: 46,550 shares worth $1.28M.
  • Gerald L. Ray & Associates added most to American International in Q3 2013, an estimated $430K increase.
  • Gerald L. Ray & Associates's biggest Q3 2013 reduction was Regeneron Pharmaceuticals, cutting an estimated $224K.
  • Gerald L. Ray & Associates fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $326K.
  • Gerald L. Ray & Associates's ten largest holdings make up 27% of its $484M portfolio in Q3 2013.
  • Gerald L. Ray & Associates opened 13 new positions and closed 4 in Q3 2013.
  • Gerald L. Ray & Associates's portfolio value rose 8.3% quarter-over-quarter to $484M.

Based on Gerald L. Ray & Associates's 13F filing for Q3 2013, filed 5 Nov 2013.